These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27866948)

  • 41. Changing Patterns of Anticoagulation After Total Hip Arthroplasty in the United States: Frequency of Deep Vein Thrombosis, Pulmonary Embolism, and Complications With Rivaroxaban and Warfarin.
    Glassberg MB; Lachiewicz PF
    J Arthroplasty; 2019 Aug; 34(8):1793-1801. PubMed ID: 31005440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
    Suen K; Westh RN; Churilov L; Hardidge AJ
    J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
    Quinlan DJ; Eriksson BI
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylaxis against pulmonary embolism in patients undergoing total hip arthroplasty.
    Khatod M; Inacio MC; Bini SA; Paxton EW
    J Bone Joint Surg Am; 2011 Oct; 93(19):1767-72. PubMed ID: 22005861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Updates in venous thromboembolism management: evidence published in 2016.
    Bartlett M; Mauck KF; Bierle DM; Saadiq RA; Daniels PR
    Hosp Pract (1995); 2017 Aug; 45(3):65-69. PubMed ID: 28604136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspirin Administered for Venous Thromboembolism Prophylaxis May Protect Against Stiffness Following Total Knee Arthroplasty.
    Shohat N; Ludwick L; Sutton R; Chisari E; Parvizi J
    J Arthroplasty; 2022 May; 37(5):953-957. PubMed ID: 35026368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors.
    Parvizi J; Huang R; Raphael IJ; Arnold WV; Rothman RH
    Clin Orthop Relat Res; 2014 Mar; 472(3):903-12. PubMed ID: 24264881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meta-analysis of low molecular weight heparin versus placebo in patients undergoing total hip replacement and post-operative morbidity and mortality since their introduction.
    Tasker A; Harbord R; Bannister GC
    Hip Int; 2010; 20(1):64-74. PubMed ID: 20383852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thromboembolism Prophylaxis in Hip Arthroplasty: Routine and High Risk Patients.
    Nam D; Nunley RM; Johnson SR; Keeney JA; Clohisy JC; Barrack RL
    J Arthroplasty; 2015 Dec; 30(12):2299-303. PubMed ID: 26182980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are Revision Hip Arthroplasty Patients at Higher Risk for Venous Thromboembolic Events Than Primary Hip Arthroplasty Patients?
    Courtney PM; Boniello AJ; Levine BR; Sheth NP; Paprosky WG
    J Arthroplasty; 2017 Dec; 32(12):3752-3756. PubMed ID: 28807468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis.
    Drescher FS; Sirovich BE; Lee A; Morrison DH; Chiang WH; Larson RJ
    J Hosp Med; 2014 Sep; 9(9):579-85. PubMed ID: 25045166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients.
    Dahl OE; Gudmundsen TE; Bjørnarå BT; Solheim DM
    Acta Orthop Scand; 2003 Jun; 74(3):299-304. PubMed ID: 12899550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspirin for thromboprophylaxis after primary lower limb arthroplasty: early thromboembolic events and 90 day mortality in 11,459 patients.
    Ogonda L; Hill J; Doran E; Dennison J; Stevenson M; Beverland D
    Bone Joint J; 2016 Mar; 98-B(3):341-8. PubMed ID: 26920959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Role of Aspirin and Unfractionated Heparin Combination Therapy Immediately After Total Hip and Knee Arthroplasty.
    Sobh AH; Koueiter DM; Mells A; Siljander MP; Karadsheh MS
    Orthopedics; 2018 May; 41(3):171-176. PubMed ID: 29570760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Balance of symptomatic pulmonary embolism and symptomatic intracerebral hemorrhage with low-dose anticoagulation in recent ischemic stroke: a systematic review and meta-analysis of randomized controlled trials.
    Geeganage CM; Sprigg N; Bath MW; Bath PM
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1018-27. PubMed ID: 22516428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A mobile compression device for thrombosis prevention in hip and knee arthroplasty.
    Colwell CW; Froimson MI; Anseth SD; Giori NJ; Hamilton WG; Barrack RL; Buehler KC; Mont MA; Padgett DE; Pulido PA; Barnes CL
    J Bone Joint Surg Am; 2014 Feb; 96(3):177-83. PubMed ID: 24500578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What's New in Venous Thromboembolic Prophylaxis Following Total Knee and Total Hip Arthroplasty? An Update.
    Pierce TP; Elmallah RK; Jauregui JJ; Cherian JJ; Mont MA
    Surg Technol Int; 2015 May; 26():234-7. PubMed ID: 26055015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
    Schousboe JT; Brown GA
    J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cost-effectiveness of oral direct factor Xa inhibitors compared with low-molecular-weight heparin for the prevention of venous thromboembolism prophylaxis in total hip or knee replacement surgery.
    Mahmoudi M; Sobieraj DM
    Pharmacotherapy; 2013 Dec; 33(12):1333-40. PubMed ID: 23625693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.